Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:103:95-120.
doi: 10.1007/978-3-031-26576-1_6.

Sarcopenia and Ageing

Keith Yu-Kin Cheng  1 , Zhengyuan Bao  1   2 , Yufeng Long  1 , Chaoran Liu  1 , Tao Huang  1 , Can Cui  1 , Simon Kwoon-Ho Chow  1   3 , Ronald Man Yeung Wong  1 , Wing-Hoi Cheung  4
Affiliations

Sarcopenia and Ageing

Keith Yu-Kin Cheng et al. Subcell Biochem. 2023.

Abstract

Musculoskeletal ageing is a major health challenge as muscles and bones constitute around 55-60% of body weight. Ageing muscles will result in sarcopenia that is characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes. In recent years, a few consensus panels provide new definitions for sarcopenia. It was officially recognized as a disease in 2016 with an ICD-10-CM disease code, M62.84, in the International Classification of Diseases (ICD). With the new definitions, there are many studies emerging to investigate the pathogenesis of sarcopenia, exploring new interventions to treat sarcopenia and evaluating the efficacy of combination treatments for sarcopenia. The scope of this chapter is to summarize and appraise the evidence in terms of (1) clinical signs, symptoms, screening, and diagnosis, (2) pathogenesis of sarcopenia with emphasis on mitochondrial dysfunction, intramuscular fat infiltration and neuromuscular junction deterioration, and (3) current treatments with regard to physical exercises and nutritional supplement.

Keywords: Intramuscular fat infiltration; Mitochondrial dysfunction; Muscle mass; Muscle strength; Myosteatosis; Neuromuscular junction; Nutrition; Physical exercise; Sarcopenia.

PubMed Disclaimer

References

    1. Aare S, Spendiff S, Vuda M, Elkrief D, Perez A, Wu QH, Mayaki D, Hussain SNA, Hettwer S, Hepple RT (2016) Failed reinnervation in aging skeletal muscle. Skelet Muscle 6
    1. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B (2009) Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an international academy on nutrition and aging (IANA) task force. J Nutr Health Aging 13(10):881–889. https://doi.org/10.1007/s12603-009-0246-z - DOI
    1. Addison O, Marcus RL, Lastayo PC, Ryan AS (2014) Intermuscular fat: a review of the consequences and causes. Int J Endocrinol 2014:309570. https://doi.org/10.1155/2014/309570 - DOI
    1. Alkahtani SA (2017) A cross-sectional study on sarcopenia using different methods: reference values for healthy Saudi young men. BMC Musculoskelet Disord 18(1):119. https://doi.org/10.1186/s12891-017-1483-7 - DOI
    1. Anzell AR, Maizy R, Przyklenk K, Sanderson TH (2018) Mitochondrial quality control and disease: insights into ischemia-reperfusion injury. Mol Neurobiol 55(3):2547–2564. https://doi.org/10.1007/s12035-017-0503-9 - DOI

LinkOut - more resources